Dopamine receptor agonists and levodopa and inducing psychosis-like behavior in the MPTP primate model of Parkinson disease.
Fox
Susan H
SH
Visanji
Naomi P
NP
Johnston
Tom H
TH
Gomez-Ramirez
Jordi
J
Voon
Valerie
V
Brotchie
Jonathan M
JM
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D002144:Callithrix; D004195:Disease Models, Animal; D018491:Dopamine Agonists / Q000008:administration & dosage*; D004333:Drug Administration Routes; D004334:Drug Administration Schedule; D007980:Levodopa / Q000008:administration & dosage*; D001523:Mental Disorders / Q000188:drug therapy* / Q000209:etiology; D020734:Parkinsonian Disorders / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D012720:Severity of Illness Index; D013997:Time Factors
D018491:Dopamine Agonists; D007980:Levodopa; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine